Cardiovascular Diseases The Cost-effectiveness of a uniform versus age-dependent Cut-off for Cardiovascular Disease Prevention Screening

被引：0
|
作者：
不详
机构：
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2023年 / 28卷 / 01期
关键词：
D O I：
10.1055/a-1983-8868
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [31] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Cobiac, Linda J.
    Magnus, Anne
    Barendregt, Jan J.
    Carter, Rob
    Vos, Theo
    BMC PUBLIC HEALTH, 2012, 12
  • [32] THE POLYPILL IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: COST-EFFECTIVENESS IN THE DUTCH POPULATION
    Van Gils, P. F.
    Hamberg-Van Reenen, H. H.
    Over, E.
    de Wit, G. A.
    van den Berg, M.
    Schuit, A. J.
    Engelfriet, P. M.
    VALUE IN HEALTH, 2011, 14 (07) : A381 - A381
  • [33] Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk
    Greving, Jacoba P.
    Buskens, Erik
    Koffijberg, Hendrik
    Algra, Ale
    CIRCULATION, 2008, 117 (22) : 2875 - 2883
  • [34] Age-dependent cut-off value for the D-dimer test
    Lionarons D.
    Jeninga E.
    Brinkers M.
    Daemen K.
    Kamphuisen P.W.
    Huisarts en wetenschap, 2022, 65 (3) : 23 - 26
  • [35] Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
    Sehested, Thomas S. G.
    Bjerre, Jenny
    Ku, Seul
    Chang, Andrew
    Jahansouz, Alison
    Owens, Douglas K.
    Hlatky, Mark A.
    Goldhaber-Fiebert, Jeremy D.
    JAMA CARDIOLOGY, 2019, 4 (02) : 128 - 135
  • [36] Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis
    Kievit, Wietske
    Maurits, Jake S. F.
    Arts, Elke E.
    van Riel, Piet L. C. M.
    Fransen, Jaap
    Popa, Calin D.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (02) : 175 - 182
  • [37] COST-EFFECTIVENESS ANALYSIS OF ATORVASTATIN COMPARED TO SIMVASTATIN IN THE PREVENTION OF CARDIOVASCULAR DISEASES IN THE CZECH REPUBLIC
    Klimes, J.
    Vocelka, M.
    Dolezal, T.
    Kruntoradova, K.
    VALUE IN HEALTH, 2013, 16 (07) : A528 - A528
  • [38] A COST-EFFECTIVENESS ANA LYSIS OF ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES AND COLORECTAL CANCER
    Soon, S.
    Chia, W. J.
    Redekop, K.
    Wee, H. L.
    VALUE IN HEALTH, 2015, 18 (07) : A462 - A462
  • [39] Prevention, screening and therapy of thyroid diseases and their cost-effectiveness
    Dietlein, M
    Moka, D
    Schmidt, M
    Theissen, P
    Schicha, H
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2003, 42 (05): : 181 - 189
  • [40] Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
    Gaziano, Thomas A.
    Opie, Lionel H.
    Weinstein, Milton C.
    LANCET, 2006, 368 (9536): : 679 - 686
12345